Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: bob beck who wrote (2679)	7/12/1999 10:49:00 PM
From: bob beck	Read Replies (3) \| Respond to of 4140

Want to laugh: This is from the Sturza home page: I wonder what their on-line assesment of the FDA panel meeting next week will be when the procedure is approved. bob Sturza's Institutional Research provides independent, unbiased medical technology assesments on a soft-dollar basis. These assessments are supplemented by our consulting arrangements with more than 600 clinical researchers at many of the leading research centers in the United States. Our research is intended for institutional investors who are unsatisfied with Wall Street research that is heavily influenced by investment banking relationships. We are an independent research company that does not have any banking or brokerage affiliations. Approximately half of our reports are buy/sell recommendations with near-term trigger events. Clients receive in-depth technology assessments, on-line analysis of FDA panel meetings and telephone consultations. If you would like more information about this service, please contact Evan Sturza at 212-541-8200.